National Pharmacy Health & Leadership Alliance Verify a MemberMember Login

NPHLA Daily

NPHLA Daily

Monday, November 16, 2026 · 3-minute read

Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.

What changed today in Aesthetics & Longevity: 2 new studies

NPHLA tracked 2 new official records on this desk today: 2 new studies. First: New research in Lasers in medical science: “Exosome-based topical formulations as adjuncts to fractional Nd: YAG laser for postoperative facial scars”.

Exosome-based topical formulations as adjuncts to fractional Nd: YAG laser for postoperative facial scars

From Lasers in medical science.

Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…

November 26, 2026 — verified from the Federal Register comments_close_on.

5 things to know

  1. What changed today in Aesthetics & Longevity: 2 new studies
  2. Exosome-based topical formulations as adjuncts to fractional Nd: YAG laser for postoperative facial scars (Lasers in medical science)
  3. Intradermal Injection of Exocean Plant Derived Exosomes: Human Scalp Histological and Morphometric Changes (Plastic and reconstructive surgery. Global open)

Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.